서울특별시내과

AOCC 2026 in conjunction with IMKASID 2026

Name: AOCC 2026 in conjunction with IMKASID 2026
Start: 2026-06-25
End: 2026-06-27
Location: 코엑스 1층 그랜드볼룸

6점 일반 6

주최: 대한장연구학회
일자: 2026-06-25 ~ 2026-06-27 (3일)
장소: 코엑스 1층 그랜드볼룸
수강료: 500,000원 구분별

수강료 구분별 상세보기

[등록비] 사전등록 KASID/AOCC Member 100,000원 / KASID Member/AOCC Non-member 180,000원 / Non-member 200,000원 / 제약/의료기기 300,000원 / 전공의, 전임의, 간호사, 약사, 연구원, 영양사, 군의관/공중보건의, 대학원생 70,000원 / 만 65세 이상 대한장연구학회 평생회원 KRW 20,000 / 학생 무료 / 현장등록 KASID/AOCC Member 150,000원 / KASID Member/AOCC Non-member 230,000원 / Non-member 250,000원 / 제약/의료기기 500,000원 / 전공의, 전임의, 간호사, 약사, 연구원, 영양사, 군의관/공중보건의, 대학원생 100,000원 / 만 65세 이상 대한장연구학회 평생회원 20,000원 / 학생 무료 [프로그램 관련 기타사항] (Room D, 15:50-17:20) MDT 세션은 증례 발표 세션이 아니고 증례 1-2개를 예들 들며, 질병에 대한 검사 및 치료에 대해 논의하는 다학제 토의 세션입니다.

원문 기준 · 정확한 등록비는 KMA 신청 페이지에서 확인하세요.

평점 구성

총 평점6점

필수평점0점

일반평점6점

연수평점은 3년 24점·연 8점 상한·필수 2점 요건이 있습니다. 이 행사 들으면 올해 상한까지 몇 점? →

KMA 등록 페이지에서 신청 → 평점 계산기

세부 일정 (209강 · 3일)

날짜를 눌러 해당 일자 프로그램을 펼쳐보세요.

Day 1 2026-06-25 (목) 48강

08:30~08:45 IUS 2026: What’s New for IUS in Crohn’s Disease? Room C Kayal Vizhi Nagarajan(Aster CMI Hospital)
08:45~09:05 Interactive Video Presentation 1: IUS in Crohn’s Disease - What’s Your Diagnosis? Room C Yoon-kyo An(Mater Hospital Brisbane)
09:05~09:15 IUS 2026: What’s New for IUS in Ulcerative Colitis? Room C Alex Hwong-Ruey Leow(Pantai Hospital Kuala Lumpur)
09:15~09:35 Interactive Video Presentation 2: IUS in Ulcerative Colitis - What’s Your Diagnosis? Room C Joyce Wing Yan Mak(The Chinese University of Hong Kong)
09:35~10:05 Interactive Video Case Presentations 3: Scoring Activity and Response in Crohn’s Disease and Ulcerative Colitis Room C Kerri Novak(University of Calgary)
10:20~10:45 Interactive Case Presentation 4: Detecting Complications in Crohn’s Disease Room C Sung Wook Hwang (University of Ulsan)
10:45~11:10 Interactive Case Presentation 5: TPUS Room C Shintaro Sagami (Kitasato University )
11:10~11:35 Interactive Case Presentation 6: Pregnancy, Post op, and beyond IBD Room C Ryan Mathias(The Queen Elizabeth Hospital)
11:35~11:55 IUS and Future Development Room C Mariangela Allocca(IRCC San Raffaele Hospital)
11:55~12:30 Module 3 Post-Course Test Room C Jeongkuk Seo (Chung-Ang University)
14:00~14:20 From Microbes to Metabolites: Postbiotic Insights into Gut Immune–Metabolic Cross-Talk Room C Munhyung Bae(Gachon University)
14:20~14:40 Multi-Biome Analysis Identifies Distinct Gut Microbial Signatures and Their Crosstalk in IBD Room C Shintaro Akiyama(University of Tsukuba)
14:40~15:00 Anti-Commensal IgG as a Pathogenic Driver of Intestinal Inflammation in Inflammatory Bowel Disease Room C Kwang Soon Kim(POSTECH)
15:00~15:20 Multi-Omics Analysis for Early Prediction and Mechanistic Insights into GI-GVHD Room C Seung Bum Lee(University of Ulsan)
15:20~15:30 Discussion Room C
15:50~16:10 Practical Therapeutic Strategies for 5-ASA, Steroids, and Immunomodulators Room C Dae Sung Kim(Konyang University)
16:10~16:30 Initiating Advanced Therapy: Choosing the Right Biologic or Small Molecule for the Right Patient Room C Kang-Moon Lee(The Catholic University of Korea)
16:30~16:50 Seeing Beyond the Lesion: IBD Dysplasia Management Today Room C Eun Ran Kim(Sungkyunkwan University)
16:50~17:10 IBD as a Multisystem Disease: Managing Extraintestinal Manifestations Room C Han Hee Lee(The Catholic University of Korea)
17:10~17:20 Discussion Room C
10:30~10:50 Past, Present and Future Directions in Medical AI Room B Jong Chul Ye (KAIST)
10:50~11:10 From Hypothesis to Model: How Clinicians Can Lead AI Study Design Room B Sang Hyun Kim(The Catholic University of Korea)
11:10~11:30 From Data to Algorithm: How AI Models Are Developed and Validated Room B Jae Gon Lee(Hanyang University)
11:30~11:50 Responsible AI Integration in Clinical Settings: Legal and Ethical Perspectives Room B A Reum Choe(Ewha Womans University)
11:50~12:00 Panel Discussion Room B
13:30~14:00 IBD Epidemiology: Evolving Trends and Future Perspectives Room B Sung Noh Hong (Sungkyunkwan University)
14:00~14:25 New Horizons in Therapeutic Targeting Beyond Endoscopic Remission Room B Marietta Iacucci(University College Cork)
14:25~14:50 Standard of care: Practical Barriers and Overcoming Strategies Room B Joyce Wing Yan Mak(The Chinese University of Hong Kong)
14:50~15:15 Personalized Treatment Strategies toward Precision Medicine Room B Joana Torres(University of Lisbon)
15:15~15:30 Discussion Room B
15:50~16:10 AI Revolution in Ulcerative Colitis Endoscopy Room B Kento Takenaka(Institute of Science Tokyo)
16:10~16:30 Training AI to Detect What Pathologists See: Inflammation in IBD Histology Room B Ji Eun Kim(Sungkyunkwan University)
16:30~16:50 The LLM Revolution in IBD Room B Chang Seok Bang(Hallym University)
16:50~17:10 Implementing AI in IBD Care: Challenges and Future Perspectives Room B Marietta Iacucci(University College Cork)
17:10~17:20 Discussion Room B
09:20~09:50 Empowering IBD Care Through Education: Insights from the China Experience Room D Yan Chen(Zhejiang University)
09:50~10:10 From First Symptom to Specialist: Reducing Delays in IBD Diagnosis Room D Luan Minh Dang(University Medical Center, Ho Chi Minh City University of Medicine and Pharmacy)
10:10~10:30 Implementing IUS in IBD Service in Indonesia: Challenges and Opportunities Room D Rabbinu Rangga Pribadi(Cipto Mangunkusumo National Central General Hospital)
10:30~10:50 Management of Rectal Neuroendocrine Tumors in Mongolia Room D Bayasgalan Luvsandagva(Ulaanbaatar Songdo Hospital)
10:50~11:10 Artificial Intelligence in Colonoscopy: Screening and Surveillance in Asia Perspective Room D Satimai Aniwan(Chulalongkorn University)
11:10~11:20 Discussion Room D
11:30~11:55 Current Situation of Intestinal Diseases in Mongolia Room D Ariunzul Dashdondog (First Central Hospital of Mongolia)
11:55~12:20 The Changing Epidemiology of IBD in Korea: Past, Present, and Future Room D Hongsub Lee(Inje University)
12:20~12:30 Discussion Room D
15:50~16:20 [MDT Case Discussion] A 15-Year-Old Man Presented with Abdominal Pain Room D Tae Hyeong Kim(Kyung Hee University)
16:20~16:50 [MDT Case Discussion] A 78-Year-Old Woman Presented with Fever Room D Motoi Uchino(Hyogo Medical University)
16:50~17:20 [MDT Case Discussion] A 51-year-old man with ASUC and psoriasis Room D Yubei Gu(Shanghai Jiao Tong University)
17:10~17:20 Discussion Room D

Day 2 2026-06-26 (금) 134강

08:30~08:50 Seeing Patterns, Shaping Care: The Evolution of Big Data in IBD Research Room B Gilaad G. Kaplan(University of Calgary)
08:50~09:10 Real-World Data in Action: Unlocking Insights from the Korean National Claims Data Room B Hyuk Yoon(Seoul National University)
09:10~09:30 Nationwide Big Data Insights into the Epidemiology and Trends of IBD in Taiwan Room B Shu-Chen Wei(National Taiwan University)
09:30~09:50 Toward Prevention: Expanding Perspectives on Early-Life and Environmental Risk Factors Room B Sun-Ho Lee(University of Toronto)
09:50~10:00 Discussion Room B
11:20~11:32 AOCC Plenary Session [초록발표] Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression Room A+B+C+D+E+F Jihye Park(Ewha Womans University)
11:32~11:44 AOCC Plenary Session [초록발표] Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk Room A+B+C+D+E+F Jie Chen(The Third Xiangya Hospital of Central South University)
11:44~11:56 AOCC Plenary Session [초록발표] Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility Room A+B+C+D+E+F Rirong Chen(University of Toronto)
11:56~12:10 AOCC Plenary Session [초록발표] Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis Room A+B+C+D+E+F Tadakazu Hisamatsu(Kyorin University)
13:00~13:20 Optimizing Treatment Strategies in Ulcerative Colitis with Upadacitinib Room B Byong Duk Ye(University of Ulsan)
13:20~13:40 Shaping a New Paradigm in Crohn’s Disease Management: The Role of Upadacitinib Room B Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science)
14:30~14:38 [초록발표] Combined acetaldehyde metabolism burden modifies IBD susceptibility to alcohol consumption: a cross-population multi-ethnic cohort study with validation from integrated genetic, proteomics and metabolomics analyses Room B Yang Guo (The Third Xiangya Hospital of Central South University, Central South University, The Third Xiangya Hospital of Central South University)
14:38~14:46 [초록발표] Integrating the environmental and genetic architectures of incident IBD: comprehensive exposome-wide and genetic analyses Room B Kejia Ma(The Third Xiangya Hospital of Central South University, Tianjin Medical University)
14:46~14:54 [초록발표] Risk of Inflammatory Bowel Disease Following Hospital-Treated Infections and Modulatory Role of Host Genetics to support a multi-hit pathogenesis model Room B Lintao Dan (Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, The Third Xiangya Hospital of Central South University)
14:54~15:02 [초록발표] Association Between Medication and Cancer Incidence in Patients with Inflammatory Bowel Disease: A Population-Based, Nested Case-Control Study Room B Jeongkuk Seo (Chung-Ang University)
15:02~15:10 [초록발표] Lonely Minds, Inflamed Guts: Metabolic and Circulating Protein Pathways Linking Social Isolation and Loneliness to Inflammatory Bowel Disease Room B Jianhui Zhao(Zhejiang University, Massachusetts General Hospital and Harvard Medical School)
15:10~15:18 [초록발표] Performance and Treatment-Dependent Behavior of Clinically Available Biomarkers for Endoscopic Recurrence in Postoperative Crohns Disease Room B Kento Sadashima (Saga University, Saga chuo public hospital)
15:18~15:26 [초록발표] Distinct IFNG-Driven Inflammation and Epithelial Metabolic Reprogramming Differentiate Intestinal Tuberculosis From Ileocecal Crohn’s Disease Room B Lexi Wu(Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine)
15:26~15:34 [초록발표] Clinical Significance of Small Bowel Capsule Endoscopy for Predicting Postoperative Endoscopic Recurrence in Patients with Postoperative Crohn’s Disease: J-PROSPECT Study Room B Motohiro Esaki (Saga University)
15:34~15:42 [초록발표] Admission factors of steroid refractoriness in a prospective cohort of patients with Acute Severe Ulcerative Colitis (ASUC): Preliminary analysis of a KASID multicenter study Room B Seoyoon Choi(Severance Hospital, Yonsei University College of Medicine)
15:42~15:50 [초록발표] Pharmacogenetics and Metabolite-Guided Optimization of Thiopurine Therapy in Taiwanese Inflammatory Bowel Disease Room B Meng-Tzu Weng(National Taiwan University Hospital and College of Medicine, National Taiwan University Hospital, Hsin-Chu Branch)
15:50~16:00 Discussion Room B
16:20~16:40 Dietary and Environmental Risk Factors in IBD: Theory and Practice Room B Rupa Banerjee(AIG Hospitals)
16:40~17:00 Impact of Diet and Urban Environment in Crohn’s Disease: Diet-omics Cohort Study Room B Rui Feng(Sun Yat-Sen University)
17:00~17:20 Tools and Challenges of Dietary Assessment in IBD and Colorectal Diseases: Lessons From Clinical Experiences Room B Yun Jeong Lim(Dongguk university)
17:20~17:40 Recent Advances in ENTERAL Nutrition for IBD: Beyond THE WALLS Room B Robert V Bryant(The Queen Elizabeth Hospital)
17:40~17:50 Discussion Room B
08:30~08:50 Microbial Signatures in IBD: Toward Precision Diagnosis and Subtype Stratification Through Multi-Omics Room C Chang Kyun Lee(Kyung Hee University)
08:50~09:10 Shaping the Gut Microbiome: Therapeutic Interventions and Clinical Implications for Inflammatory Bowel Disease Room C Hong Koh(Yonsei University)
09:10~09:30 Microbiota-Mediated Intestinal Fibrosis In Crohn’s Disease : From Correlation To Causality Room C Ren Mao(Sun Yat-sen University)
09:30~09:50 Microbes as Targets, Mediators, and Predictors of Therapy Response in IBD Room C Eytan Wine(The Hospital for Sick Children)
09:50~10:00 Discussion Room C
11:20~11:32 [초록발표] Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression Room A+B+C+D+E+F Jihye Park(Ewha Womans University)
11:32~11:44 [초록발표] Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk Room A+B+C+D+E+F Jie Chen(The Third Xiangya Hospital of Central South University)
11:44~11:56 [초록발표] Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility Room A+B+C+D+E+F Rirong Chen(University of Toronto)
11:56~12:10 [초록발표] Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis Room A+B+C+D+E+F Tadakazu Hisamatsu(Kyorin University)
13:00~13:20 Real-World Experience with Subcutaneous Infliximab: Updated Global Evidence Room C Silvio Danese (University Vita-Salute San Raffaele)
13:20~13:40 Personalizing IBD Treatment: The Role of Therapeutic Drug Monitoring in Infliximab Therapy Room C Sung Noh Hong(Sungkyunkwan University)
14:30~14:38 [초록발표] Metachronous Advanced Neoplasia in Patients With Over10 Adenomas: A Large Multicenter Cohort Analysis Room C Seung Wook Hong(University of Ulsan)
14:38~14:46 [초록발표] Impact of Topical Powder Application After ESD for Large Colorectal Lesions: A KASID Multicenter Randomized Controlled Trial Room C Yunho Jung(Soonchunhyang University)
14:46~14:54 [초록발표] Clinical Significance of Close Vertical Resection Margin (0.1-1mm) in T1 Colorectal Cancer After Endoscopic Submucosal Dissection: A Multicenter Retrospective Study Room C Hyung-Hoon Oh(Chonnam National University Medical School)
14:54~15:02 [초록발표] Diagnostic Utility of Endoscopic Features and Endoscopic Ul-trasonography for Ulcerative Colitis-Associated Neoplasia: A Retrospective Study on the Role of Endoscopic Submucosal Dissection as a Total Biopsy Room C Yoriaki Komeda (Kindai University Faculty of Medicine)
15:02~15:10 [초록발표] Outcomes of Additional Surgery Versus Surveillance After Noncurative Endoscopic Resection of High-Risk T1 Colorectal Cancer: HASID multicenter study Room C Hyung-Hoon Oh(Chonnam National University Medical School)
15:10~15:18 [초록발표] Comparison of Stool DNA Based SDC2 Methylation Testing and Repeat FIT for Advanced Colorectal Neoplasia in FIT Positive Individuals: A Multicenter Prospective Exploratory Study Room C Youngik Kim(Yonsei University Wonju college of Medicine)
15:18~15:26 [초록발표] Comparison Extremely Early-Onset Colorectal Cancer(EEO-CRC) versus Extremely Late-Onset Colorectal Cancer(ELO-CRC) in Chungcheongnam-do: the CHungcheong Association for the Study of Intestinal Disease(CHASID) multicenter study Room C Doohyuck Lee(Dankook University Hospital)
15:26~15:34 [초록발표] Bleeding Risk After Therapeutic Colonoscopy by Anticoagulant Type: A Retrospective Multicenter Cohort Study Room C Min-Jae Kim(Yonsei University College of Medicine)
15:34~15:42 [초록발표] Acceptance of Family-Based Interventions for Colorectal Cancer Screening: Assessing Adult Children as Digital Care Partners Room C Jeongkuk Seo(Chung-Ang University)
15:42~15:50 [초록발표] Combined application of modified colorectal cancer risk scoring and fecal immunochemical testing for early detection of colorectal cancer Room C Temuulen Tsedensodnom(Mongolian National University of Medical Sciences)
15:50~16:00 Discussion Room C
16:20~16:40 Current Status and Treatment Trends of IBD in Taiwan Room C Tzung-Jiun Tsai(Kaohsiung Veterans General Hospital)
16:40~17:00 Current Status and Treatment Trends of IBD in Korea Room C Joo Hye Song(Konkuk University)
17:00~17:20 Current Status and Treatment Trends of Colorectal Cancer in Taiwan Room C Li-Chun Chang(National Taiwan University)
17:20~17:40 Current Status and Treatment Trends of Colorectal Neoplasms in Korea Room C Seong-Jung Kim(Chosun University)
17:40~17:50 Discussion Room C
08:30~08:50 Anti-TNF Therapy: Still Standing Strong and Getting Smarter Room A Byong Duk Ye(University of Ulsan)
08:50~09:10 Anti-Integrin Therapy: Ensuring Safety, Enhancing Efficacy Room A Vipul Jairath(Western University)
09:10~09:30 IL-23 Inhibitors: Navigating the Expanding Choices in IBD Care Room A Silvio Danese(University Vita-Salute San Raffaele)
09:30~09:50 JAK Inhibitors and S1P Receptor Modulators: Emerging Contenders Beyond Biologics Room A Taku Kobayashi(Kitasato University)
09:50~10:00 Discussion Room A
10:20~11:20 Opening Ceremony Room A
11:20~11:32 [초록발표] Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression Room A+B+C+D+E+F Jihye Park(Ewha Womans University)
11:32~11:44 [초록발표] Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk Room A+B+C+D+E+F Jie Chen(The Third Xiangya Hospital of Central South University)
11:44~11:56 [초록발표] Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility Room A+B+C+D+E+F Rirong Chen(University of Toronto)
11:56~12:10 [초록발표] Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis Room A+B+C+D+E+F Tadakazu Hisamatsu(Kyorin University)
13:40~14:20 KASID General Meeting & Poster Viewing Room A
14:30~14:38 [초록발표] Efficacy and Safety of Mirikizumab in Chinese Patients with Ulcerative Colitis Following 104 Weeks of Continuous Treatment: Results from the LUCENT-3 Open-Label Extension Study Room A Zhihua Ran(Shanghai University)
14:38~14:46 [초록발표] Comparative Long-term Outcomes of Treatment Strategies in Biologic-Naive Patients with Crohn Room A Han Hee Lee(The Catholic University of Korea)
14:46~14:54 [초록발표] Real-World Comparative Effectiveness and Safety of Upadacitinib plus Vedolizumab versus Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study Room A Jiayin Yao(Sun Yat-sen University)
14:54~15:02 [초록발표] Long-Term Outcomes Following Upfront Combination Therapy With Tofacitinib and Intravenous Corticosteroids in Acute Severe Ulcerative Colitis Room A Arshdeep Singh(Dayanand Medical College and Hospital)
15:02~15:10 [초록발표] Treatment outcomes of advanced therapies in patients with refractory ulcerative proctitis: a multicenter cohort study Room A Shin Ju Oh (Kyung Hee University)
15:10~15:18 [초록발표] Day 3 Stool Frequency Predicts Steroid Non-response in Korean Patients with Acute Severe Ulcerative Colitis Room A Kento Sadashima (Saga University, Saga chuo public hospital)
15:18~15:26 [초록발표] Impact of Prior Anti-IL-12/23 Exposure on Anti-TNF Effectiveness in Crohn’s Disease: A Propensity-Weighted Cohort Study Room A Lexi Wu(Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine)
15:26~15:34 [초록발표] Long-term outcomes of prophylactic scheduled endoscopic balloon dilation for Crohn’s diseaseassociated intestinal strictures Room A Motohiro Esaki (Saga University)
15:34~15:42 [초록발표] Integrated blood miR-873-5p and clinical parameters predict stricturing progression in Crohn’s disease: a prospective multi-cohort study Room A Seoyoon Choi (Severance Hospital, Yonsei University College of Medicine)
15:42~15:50 [초록발표] Cancer Risk with Advanced Therapies in Patients with Inflammatory Bowel Diseases: An Administrative Claims-based Study Room A Meng-Tzu Weng (National Taiwan University Hospital and College of Medicine, National Taiwan University Hospital, Hsin-Chu Branch)
15:50~16:00 Discussion Room A
16:20~16:40 Pregnancy in IBD: Essential Knowledge for Clinicians and Patients Room A Joana Torres(University of Lisbon)
16:40~17:00 IBD and Pregnancy in East Asia: Regional Insights and Clinical Experience Room A Eun Mi Song(Ewha Womans University)
17:00~17:20 Epidemiology and Pathophysiology of Obesity and IBD: Asian Perspectives Room A Jaeyoung Chun(Yonsei University)
17:20~17:40 Optimizing Medical Therapy in IBD Patients with Obesity Room A Siddharth Singh(Mayo Clinic Arizona)
17:40~17:50 Discussion Room A
08:30~08:50 FIT or Colonoscopy: What Is the Best Strategy for CRC Screening? Room D Wen-Feng Hsu(National Taiwan University)
08:50~09:10 Personalized Screening Strategies: Beyond Age-Based CRC Guidelines Room D Jae Myung Cha(Kyung Hee University)
09:10~09:30 Revolutionizing Biomarkers in Colorectal Cancer Screening Room D Francis K.L. Chan(The Chinese University of Hong Kong)
09:30~09:50 Risk-Adapted Surveillance after Polypectomy & ESD: Who, When, and How Room D Su Young Kim(Yonsei University)
09:50~10:00 Discussion Room D
11:20~11:32 [초록발표] Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression Room A+B+C+D+E+F Jihye Park(Ewha Womans University)
11:32~11:44 [초록발표] Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk Room A+B+C+D+E+F Jie Chen(The Third Xiangya Hospital of Central South University)
11:44~11:56 [초록발표] Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility Room A+B+C+D+E+F Rirong Chen(University of Toronto)
11:56~12:10 [초록발표] Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis Room A+B+C+D+E+F Tadakazu Hisamatsu(Kyorin University)
14:30~14:38 [초록발표] Functional photoacoustic/ultrasound imaging for assessing the treatment target in ulcerative colitis Room D Yue Li (Peking Union Medical College Hospital)
14:38~14:46 [초록발표] PRISM: integrating intestinal ultrasound activity, structural features, and C-reactive protein to predict histological activity in ulcerative colitis: a prospective cross-sectional study Room D Jing-Xing Li (China Medical University Hospital)
14:46~14:54 [초록발표] Patient Perceptions and Satisfaction with Intestinal Ultrasound in Inflammatory Bowel Disease: A Multicenter Cross-Sectional Survey Room D Jueon Hong (Asan Medical Center, University of Ulsan College of Medicine)
14:54~15:02 [초록발표] Transperineal ultrasound for early identification of corticosteroid non-response in acute severe ulcerative colitis (TRANSPIRE): a prospective pilot study Room D Deloshaan Subhaharan(Gold Coast University Hospital, Bond University)
15:02~15:10 [초록발표] Early Quantitative Intestinal Ultrasound Response Predicts One-Year Endoscopic Remission in Crohn’s Disease: A Prospective Treat-to-Target Cohort Study using IBUS-SAS score Room D Kayal Vizhi Nagarajan(Aster CMI Hospital)
15:10~15:18 [초록발표] Latent-Space Multimodal Deep Learning for Predicting Disease-Behavior Progression in Long-Standing Crohn’s Disease: An Interpretable and Clinically Deployable AI Framework Room D Hanqiao Dai (Peking Union Medical College Hospital- Chinese Academy Medical Sciences & Peking Union Medical College)
15:18~15:26 [초록발표] Deep Learning of Pre-treatment Spatial Pathological Signatures Predicts Long-Term Endoscopic Healing to Vedolizumab in Ulcerative Colitis: A Multicenter Study Room D Yadi Lan (Tianjin Medical University General Hospital)
15:26~15:34 [초록발표] Multimodal Deep Learning for Predicting High-Risk Pathological Features in Superficial Colorectal Cancer Room D Junghun Han(Yonsei University Wonju College of Medicine)
15:34~15:42 [초록발표] Evaluating Multimodal Large Language Model Pipelines for Colonic Polyp Detection and Boundary Estimation Room D Eue Young Kim(Seoul National University Hospital, Seoul National University College of Medicine)
15:42~15:50 [초록발표] Can AI-assisted 6-minute Colonoscopy Achieve a 35% Qualified Adenoma Detection Rate? A single-center Randomized Controlled Trial in China Room D Haoyan Zhang (The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University)
15:50~16:00 Discussion Room D
16:20~16:40 Early-Onset Pediatric IBD: From Immune Pathways to Clinical Application Room D Takashi Ishige(Gunma University)
16:40~17:00 Pediatric Ulcerative Colitis: Key Updates from the Latest ECCO–ESPGHAN Guidelines Room D Eytan Wine(The Hospital for Sick Children)
17:00~17:20 Real-World Practice of Nutritional Therapy in Pediatric Crohn’s Disease Room D Hyeji Lim (Yonsei University)
17:20~17:40 Practical Precision Medicine in Pediatric IBD: Advanced Therapies in Real-World Settings Room D Mi Jin Kim(Sungkyunkwan University)
17:40~17:50 Discussion Room D
14:30~14:38 [초록발표] Non-toxin-mediated Clostridioides difficile colonization drives microbial dysbiosis and early inflammatory priming in IBD Room E Gwanghee Kim(Seoul National University Hospital)
14:38~14:46 [초록발표] Microbial metabolite hyodeoxycholic acid induces macrophage immunometabolic reprogramming and alleviates ulcerative colitis Room E Yaping An(Tianjin Medical University General Hospital)
14:46~14:54 [초록발표] Age-Related Microbial Differences in Newly Diagnosed Crohn Room E Yun-Seok Jeong(Kyung Hee University)
14:54~15:02 [초록발표] Heterogeneous Dysbiotic Pathotypes and Longitudinal Dynamics of the Gut Microbiome in Ulcerative Colitis Patients Room E Yeonjae Jung(CJ Bioscience, Inc.)
15:02~15:10 [초록발표] Pyridoxamine Depletion and Redox-Associated Microbial Restructuring in Ulcerative Colitis Room E Sho Tanaka (Hokkaido University Hospital)
15:10~15:18 [초록발표] Endothelial PIEZO1 Activates the HIF1A-Driven Lactate Shuttle that Reprograms Macrophage Transmigration and Polarization in IBD Room E Chang Liang (West China Hospital of Sichuan University)
15:18~15:26 [초록발표] Granzyme K CD8+ T Cells with Tissue-Resident Features Promote Intestinal Inflammation in Patients with Crohn Room E Yoonho Lee (Brain Korea 21 project, Asan Medical Center, University of Ulsan College of Medicine)
15:26~15:34 [초록발표] Anti-IL-12/23p40 Is Associated with Superior Anti-fibrotic Effects Compared with Anti-TNF and Anti-alpha4beta7 Room E Han Na Kim(Kyungpook National University)
15:34~15:42 [초록발표] Neutrophil-Secreted Grancalcin Reprograms Mesenchymal Stem Cell Fate via HSPA5 to Drive Pathologic Creeping Fat in Crohn Room E Fengfei Wu(Nanfang Hospital, Southern Medical University)
15:42~15:50 [초록발표] Suppression of CPT1A-mediated Fatty Acid beta-Oxidation promotes fibroblast activation and intestinal fibrosis in Crohn Room E Zhiyin Feng(The First Affiliated Hospital of Sun Yat-Sen University)
15:50~16:00 Discussion Room E
14:30~14:38 [초록발표] Lymphoma and Colorectal cancer in pediatric-onset inflammatory bowel disease: A 15-year nationwide population-based study in South Korea Room F Eun Sil Kim(Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
14:38~14:46 [초록발표] Distinct Gut Microbiota and Bile Acid Profiles in Pediatric Inflammatory Bowel Disease versus Functional Gastrointestinal Disorders: Implications for Non-invasive Differential Diagnosis Room F Xi He(Capital Center for Children\)
14:46~14:54 [초록발표] Subcutaneous versus Intravenous Double-Dose Infliximab for Dose Intensification in Pediatric-Onset Crohn Room F Tae Jong Jeong (Samsung Medical Center)
14:54~15:02 [초록발표] Preoperative food-related quality of life associated with clinical outcomes in patients with ulcerative colitis after ileal pouch-anal anastomosis: Results from China UC Pouch Center Union Room F Weimin Xu(Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China)
15:02~15:10 [초록발표] Left-Sided Ileostomy Reduces Stoma Outlet Obstruction after Ileal PouchAnal Anastomosis for Ulcerative Colitis: A Randomized Controlled Trial Room F Ryuichi Kuwahara(Hyogo Medical University)
15:10~15:18 [초록발표] Synergistic Effects of Partial Enteral Nutrition Combined with Ustekinumab in Induction and Maintenance Therapy for Crohn’s Disease: Real-World Experience from a Multicentre Cohort Room F Yuan Zeng(The Sixth Affiliated Hospital, Sun Yat-sen University, Biomedical Innovation Center, the Sixth Affiliated Hospital, Sun Yat-sen University)
15:18~15:26 [초록발표] Aligning Patient and Planetary Health: Planetary Health Diet Adherence and Inflammatory Bowel Disease Prognosis across Western and Eastern Cohorts Room F Haiting Shu(The Third Xiangya Hospital of Central South University, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine)
15:26~15:34 [초록발표] Barriers and Facilitators to Crohn’s Disease Exclusion Diet Adoption in Malaysian Adults with Crohn’s Disease Room F Nazihah Wafi (University of Malaya)
15:34~15:42 [초록발표] Small Bowel Rebleeding After Capsule Endoscopy: Effects of Device-Assisted Enteroscopy on Small Bowel Rebleeding Probability, Risk Factors, and Mortality in a Nationwide Big Data Cohort Room F Joo Hye Song (Konkuk University)
15:42~15:50 [초록발표] Life-Course Psychosocial Stress and Incident Irritable Bowel Syndrome Room F Jianhui Zhao(Massachusetts General Hospital and Harvard Medical School, Zhejiang University)
15:50~16:00 Discussion Room F
14:30~14:45 Optimizing IBD Outcomes Across the Lifespan: Differential Positioning of Biologics and Small Molecules from Pediatrics to Adulthood Room G Junghyun Noh(Seoul National University)
14:45~15:00 Clinical Characteristics and Surgical Outcomes of Adolescent-Onset Crohn’s Disease Compared with Pediatric- and Adult-Onset DiseaseA Nationwide Multicenter Retrospective Cohort Study (CONNECT Study Group) Room G Soojin KangMinjee Kim(Ewha Womans UniversitySungkyunkwan University)
15:00~15:15 Tailoring Colorectal Cancer Screening for Older Adults: Strategies Beyond Routine Colonoscopy Room G Geunhyuk Choi(Soonchunhyang University)
15:15~15:30 The Future of CRC Screening : Moving Beyond FIT Room G Yeojin Lee(University of Ulsan)
15:30~15:45 Artificial Intelligence in Capsule Endoscopy: Current Landscape and Future Perspectives Room G Kwangmin Joo(Dong-A University)
15:45~16:00 Gut Microbiome in Inflammatory Bowel Disease: From Dysbiosis to Personalized Therapy Room G Hee Won Kwon(Kyungpook National University)

Day 3 2026-06-27 (토) 27강

08:30~08:50 AOCC Guidelines for the Diagnosis of IBD Room A Jun Shen(Shanghai Jiao Tong University)
08:50~09:10 AOCC Guidelines for the Treatment of UC Room A Dong Hyun Kim(Chonnam National University)
09:10~09:30 AOCC Guideline for the Treatment of Crohn’s Disease Room A Shintaro Akiyama(University of Tsukuba)
09:30~09:50 Shaping the Future of the KASID Guidelines Room A Won Moon(Kosin University)
09:50~10:00 Discussion Room A
10:20~10:50 IBD Goes Global: Western Perspectives on the Rising Burden in Asia Room A Gilaad G. Kaplan(University of Calgary)
10:50~11:20 Emerging Therapeutics in IBD: Which Are the Most Promising? Room A Jae Hee Cheon(Yonsei University)
11:20~11:50 IBD Tomorrow: From Prediction to Prevention Room A David T. Rubin(University of Chicago)
08:30~08:50 Optimal Timing and Perioperative Care for IBD Surgery Room B Gyoung Tae Noh(Ewha Womans University)
08:50~09:10 Surgical Techniques and Tips for Bowel Anastomosis in IBD Room B Jong Lyul Lee(University of Ulsan)
09:10~09:30 Overcoming Postoperative Complications after IBD Surgery Room B Sohyun Kim(Yeungnam University)
09:30~09:50 Surgery for IBD-Associated Cancer/Dysplasia Room B Motoi Uchino(Hyogo Medical University)
09:50~10:00 Discussion Room B
10:20~10:40 Defining and Monitoring Small Bowel Strictures in Crohn’s Disease Room B Kerri Novak(University of Calgary)
10:40~11:00 Opening the Way: Advanced Endoscopic Interventions for Crohn’s Strictures Room B Hironori Yamamoto(Jichi Medical University)
11:00~11:20 Inside the Hidden Zone: Optimizing Medical Management for Perianal Fistulas Room B Siddharth Singh(Mayo Clinic Arizona)
11:20~11:40 Surgical Therapies for Complex Perianal Fistula: A Surgeon Room B Ki-Yun Lim(Seoul Songdo Hospital)
11:40~11:50 Discussion Room B
08:30~08:50 AI-Assisted Decision-Making in Early-Stage Colorectal Cancer: Current Applications and Future Directions Room C Jonathan W. J. Lee(National University Hospital)
08:50~09:10 Optimizing Endoscopic Treatment for T1 Colorectal Cancer: How Far Can We Go? Room C Yunho Jung(Soonchunhyang University)
09:10~09:30 Expanding the Role of Endoscopic Treatment in T2 Colorectal Cancer: Opportunities and Limitations Room C Katsuro Ichimasa(Showa Medical University)
09:30~09:50 Selecting Surgery after Non-Curative ESD: Optimal Timing and Criteria Room C Dae-hee Pyo(The Catholic University of Korea)
09:50~10:00 Discussion Room C
10:20~10:40 Nutritional Management for IBD Patients Room C Jihye Park(Yonsei University)
10:40~11:00 Vaccination in IBD: Key Updates for Nursing Practice Room C Yehyun Park(Ewha Womans University)
11:00~11:20 IBD Nursing in Education and Psychological Support: Practical Approaches and Lessons from Experience Room C Shin Ae Lee(Yonsei University)
11:20~11:50 Panel Discussion Room C